Journal of the American Society of Nephrology
2007 JASN IMPACT FACTOR 7.111 HOME   AUTHOR INFO   EDITORIAL BOARD   SUBSCRIBE   FEEDBACK   ALERTS   HELP 
    advanced
CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maric, C.
Right arrow Articles by Hinojosa-Laborde, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maric, C.
Right arrow Articles by Hinojosa-Laborde, C.
J Am Soc Nephrol 15:1546-1556, 2004
© 2004 American Society of Nephrology


BASIC SCIENCE

Glomerulosclerosis and Tubulointerstitial Fibrosis are Attenuated with 17{beta}-Estradiol in the Aging Dahl Salt Sensitive Rat

Christine Maric*, Kathryn Sandberg* and Carmen Hinojosa-Laborde{dagger}

*Center for the Study of Sex Differences in Health, Aging and Disease, Georgetown University, Washington, DC; and {dagger}Department of Anesthesiology, University of Texas Health Science Center, San Antonio, Texas.

Correspondence to Dr. Christine Maric, Center for the Study of Sex Differences: in Health, Aging and Disease, Georgetown University Medical Center, 394 Bldg D, 4000 Reservoir road NW, Washington, DC, 20057. Phone: 202 687 5363; Fax: 202 687 7278; E-mail: cm255{at}georgetown.edu

ABSTRACT. This study examined the effects of estrogen deficiency by ovariectomy (OVX) and 17{beta}-estradiol (E2) replacement (OVX+E2) on glomerulosclerosis and tubulointerstitial fibrosis and the mechanisms contributing to these changes, including expression of collagen type IV and laminin, transforming growth factor-{beta} (TGF-{beta}), and activity of matrix metalloproteinases (MMP) in the kidneys of young (4 mo [4M]) and aged (12 mo [12M]) Dahl salt-sensitive (DSS) rats maintained on a low-salt (0.1% NaCl) diet. While normal renal morphology was observed in the 4M rats in all treatment groups, moderate to severe glomerulosclerosis (glomerulosclerotic index [GSI]: 4M, 0.22 ± 0.09 versus 12M, 1.43 ± 0.17; P < 0.001) and cortical tubulointerstitial fibrosis (CTIFI: 4M, 0 versus 12M, 57.1 ± 4.9; P < 0.01) was observed in the 12M rats. The severity of glomerulosclerosis and cortical tubulointerstitial fibrosis in the 12M group was augmented with OVX (GSI, 3.27 ± 0.34; CTIFI, 74.4 ± 9.2; P < 0.01 versus Intact at 12M) and attenuated with E2 replacement ([GSI], 1.09 ± 0.09; CTIFI, 49.2 ± 6.8). In the 12M animals, OVX was also associated with increased deposition and expression of laminin (Intact, 228.1 ± 6.7; OVX, 277.4 ± 9.6 AU; P < 0.01), increased expression of TGF-{beta} (Intact, 85.0 ± 23.0; OVX, 178.0 ± 20.5 AU; P < 0.001), and decreased activity of cortical MMP-9 (Intact, 3.8 ± 0.8; OVX, 2.4 ± 0.6 AUC; P < 0.01). E2 replacement opposed these effects (laminin, 229.9 ± 6.2 AU; TGF-{beta}, 101.3 ± 25.2 AU; MMP-9, 5.2 ± 0.2 AUC). The severity of the disease in the 12M rats correlated with a modest decrease in creatinine clearance (Intact, 0.26 ± 0.01; OVX, 0.22 ± 0.01; OVX+E2, 0.28 ± 0.01 mg/min per 100 g) and increase in BUN (Intact, 20.3 ± 2.1; OVX, 32.6 ± 5.1; OVX+E2, 24.3 ± 2.4 mg/dl). The authors conclude that E2 is renoprotective in the aging DSS rat by attenuating glomerulosclerosis and tubulointerstitial fibrosis.




This article has been cited by other articles:


Home page
Exp PhysiolHome page
H. Ji, S. Menini, W. Zheng, C. Pesce, X. Wu, and K. Sandberg
Role of angiotensin-converting enzyme 2 and angiotensin(1-7) in 17{beta}-oestradiol regulation of renal pathology in renal wrap hypertension in rats
Exp Physiol, May 1, 2008; 93(5): 648 - 657.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
W. Zheng, H. Ji, C. Maric, X. Wu, and K. Sandberg
Effect of dietary sodium on estrogen regulation of blood pressure in Dahl salt-sensitive rats
Am J Physiol Heart Circ Physiol, April 1, 2008; 294(4): H1508 - H1513.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Q. Xu, C. C. Wells, J. H. Garman, L. Asico, C. S. Escano, and C. Maric
Imbalance in Sex Hormone Levels Exacerbates Diabetic Renal Disease
Hypertension, April 1, 2008; 51(4): 1218 - 1224.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Dixon and C. Maric
17beta-Estradiol attenuates diabetic kidney disease by regulating extracellular matrix and transforming growth factor-beta protein expression and signaling
Am J Physiol Renal Physiol, November 1, 2007; 293(5): F1678 - F1690.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
L. M. Yamaleyeva, K. D. Pendergrass, N. T. Pirro, P. E. Gallagher, L. Groban, and M. C. Chappell
Ovariectomy is protective against renal injury in the high-salt-fed older mRen2.Lewis rat
Am J Physiol Heart Circ Physiol, October 1, 2007; 293(4): H2064 - H2071.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
Ma. E. D. Esqueda, T. Craig, and C. Hinojosa-Laborde
Effect of Ovariectomy on Renal Estrogen Receptor-{alpha} and Estrogen Receptor-{beta} in Young Salt-Sensitive and -Resistant Rats
Hypertension, October 1, 2007; 50(4): 768 - 772.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
N. B. Ojeda, D. Grigore, E. B. Robertson, and B. T. Alexander
Estrogen Protects Against Increased Blood Pressure in Postpubertal Female Growth Restricted Offspring
Hypertension, October 1, 2007; 50(4): 679 - 685.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
R. H. Straub
The Complex Role of Estrogens in Inflammation
Endocr. Rev., August 1, 2007; 28(5): 521 - 574.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
M. Keck, M. J. Romero-Aleshire, Q. Cai, P. B. Hoyer, and H. L. Brooks
Hormonal status affects the progression of STZ-induced diabetes and diabetic renal damage in the VCD mouse model of menopause
Am J Physiol Renal Physiol, July 1, 2007; 293(1): F193 - F199.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
M. Mizobuchi, J. Morrissey, J. L. Finch, D. R. Martin, H. Liapis, T. Akizawa, and E. Slatopolsky
Combination Therapy with an Angiotensin-Converting Enzyme Inhibitor and a Vitamin D Analog Suppresses the Progression of Renal Insufficiency in Uremic Rats
J. Am. Soc. Nephrol., June 1, 2007; 18(6): 1796 - 1806.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
J. M. Catania, G. Chen, and A. R. Parrish
Role of matrix metalloproteinases in renal pathophysiologies
Am J Physiol Renal Physiol, March 1, 2007; 292(3): F905 - F911.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. W. Mankhey, C. C. Wells, F. Bhatti, and C. Maric
17beta-Estradiol supplementation reduces tubulointerstitial fibrosis by increasing MMP activity in the diabetic kidney
Am J Physiol Regulatory Integrative Comp Physiol, February 1, 2007; 292(2): R769 - R777.
[Abstract] [Full Text] [PDF]


Home page
J. Am. Soc. Nephrol.Home page
S. J. Elliot, M. Karl, M. Berho, X. Xia, S. Pereria-Simon, D. Espinosa-Heidmann, and G. E. Striker
Smoking Induces Glomerulosclerosis in Aging Estrogen-Deficient Mice through Cross-Talk between TGF-beta1 and IGF-I Signaling Pathways
J. Am. Soc. Nephrol., December 1, 2006; 17(12): 3315 - 3324.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. C. Chappell, L. M. Yamaleyeva, and B. M. Westwood
Estrogen and salt sensitivity in the female mRen(2).Lewis rat
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2006; 291(5): R1557 - R1563.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Karl, M. Berho, J. Pignac-Kobinger, G. E. Striker, and S. J. Elliot
Differential Effects of Continuous and Intermittent 17{beta}-Estradiol Replacement and Tamoxifen Therapy on the Prevention of Glomerulosclerosis: Modulation of the Mesangial Cell Phenotype in Vivo
Am. J. Pathol., August 1, 2006; 169(2): 351 - 361.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
S. Sethi, S. Iida, C. D. Sigmund, and D. D. Heistad
Renal Thrombotic Microangiopathy in a Genetic Model of Hypertension in Mice
Experimental Biology and Medicine, February 1, 2006; 231(2): 196 - 203.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
M. Chin, M. Isono, K. Isshiki, S.-i. Araki, T. Sugimoto, B. Guo, H. Sato, M. Haneda, A. Kashiwagi, and D. Koya
Estrogen and Raloxifene, a Selective Estrogen Receptor Modulator, Ameliorate Renal Damage in db/db Mice
Am. J. Pathol., June 1, 2005; 166(6): 1629 - 1636.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
R. W. Mankhey, F. Bhatti, and C. Maric
17{beta}-Estradiol replacement improves renal function and pathology associated with diabetic nephropathy
Am J Physiol Renal Physiol, February 1, 2005; 288(2): F399 - F405.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
J. F. Reckelhoff
Sex Steroids, Cardiovascular Disease, and Hypertension: Unanswered Questions and Some Speculations
Hypertension, February 1, 2005; 45(2): 170 - 174.
[Full Text] [PDF]




HOME CURRENT ISSUE ARCHIVES JASN Express ONLINE SUBMISSION AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP